‡a
Author's Adjuvant ipilimumab versus placebo after complete resection of stage III melanoma: long-term follow-up results of the European Organisation for Research and Treatment of Cancer 18071 double-blind phase 3 randomised trial
‡a
adjuvantipilimumabversusplaceboaftercompleteresectionofstage3melanomalongtermfollowupresultsoftheeuropeanorganisationforresearchandtreatmentofcancer18071doubleblindphase3randomisedtrial
‡A
Adjuvant ipilimumab versus placebo after complete resection of stage III melanoma: long-term follow-up results of the European Organisation for Research and Treatment of Cancer 18071 double-blind phase 3 randomised trial
‡9
1
‡a
granzymebdegradedtype4collagenproductsinserumidentifymelanomapatientsrespondingtoimmunecheckpointblockade
‡A
Granzyme B Degraded Type IV Collagen Products in Serum Identify Melanoma Patients Responding to Immune Checkpoint Blockade
‡9
1
‡a
improvedprogressionfreelongtermsurvivalofanationwidepatientpopulationwithmetastaticmelanoma
‡A
Improved Progression-Free Long-Term Survival of a Nation-Wide Patient Population with Metastatic Melanoma
‡9
1
